Santa Monica, United States
Kite Pharma, a subsidiary of Gilead Sciences, is a pioneering company in the Biotechnology, Health Care, and Health and Wellness industries, renowned for its commitment to cell therapy as a remedy for cancer. Founded in 2009, Kite has positioned itself as a leader in engineered T cell therapy for hematologic malignancies, operating from its corporate headquarters in the United States with manufacturing facilities in California, Maryland, and the Netherlands.
Rather than relying on traditional pharmaceutical approaches, Kite Pharma specializes in personalized therapies, where specialists reengineer a patient's immune cells to aggressively target cancer cells. This unique approach underlines their dedication to bringing transformative treatment options to a broader patient base.
The company achieved a significant milestone with an $11.90B acquisition by Gilead Sciences on 1st August, 2017, reflecting investor confidence in their innovative approach to cancer treatment.
Gamida Cell Ltd.